US Wearables in Pharma & Biotech Market (2026-2031)
The US Wearables in Pharma & Biotech Market was valued at $1602.2 Million in 2026 and projected to reach to $3973.4 Million by 2031, representing a compound annual growth rate of 19.9%. The US wearables in pharma and biotech market is positioned for sustained growth through 2031, driven by increasing healthcare digitalization, rising chronic disease prevalence, and growing investment in precision medicine initiatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Wearables in Pharma & Biotech Market Trends and Insights
- The US market is driven by increasing adoption of remote patient monitoring devices, digital therapeutics integration, and regulatory support for connected health solutions.
- In the US, wearable technologies are transforming clinical trials, patient engagement, and real-world evidence collection across pharmaceutical and biotech organizations. The US represents a critical hub for wearable innovation in healthcare, with strong investment in continuous glucose monitors, smartwatch-enabled diagnostics, and AI-powered health analytics.
- By 2031, the US market will nearly double in value, reflecting accelerating demand from both pharmaceutical companies seeking better patient outcomes and biotech firms developing next-generation monitoring platforms.
- The US regulatory environment, particularly FDA guidance on digital health and software as a medical device (SaMD), continues to facilitate market growth and commercialization of advanced wearable solutions..
Key Market Statistics
- CAGR (2026-2031) 19.9% CAGR
- Market Size, 2026 ~USD 1602.2 Million
- Forecast, 2031 ~USD 3973.4 Million
- Country US
US Wearables in Pharma & Biotech Market Overview
Market Valuation Growth :
The US wearables in pharma and biotech market is valued at $1,602.2 million in 2026 and is projected to reach $3,973.4 million by 2031, representing a robust 19.9% CAGR over the forecast period.
Remote Patient Monitoring Adoption :
US healthcare providers are increasingly deploying remote patient monitoring wearables to enhance patient outcomes, reduce hospital readmissions, and enable continuous health data collection across diverse therapeutic areas.
Regulatory Support & Digital Health Integration :
The US FDA's supportive regulatory framework for connected health solutions and digital therapeutics is accelerating market growth, with wearables becoming integral to clinical trial protocols and real-world evidence generation.
Clinical Trial Transformation :
US pharmaceutical companies are leveraging wearable technologies to streamline clinical trials through decentralized trial designs, improved patient compliance tracking, and real-time data collection capabilities.
US Wearables in Pharma & Biotech Market Dynamics
- Pharmaceutical and biotech companies are integrating wearables into drug development pipelines and post-market surveillance programs to enhance efficacy monitoring and patient safety.
- The convergence of FDA regulatory clarity, reimbursement expansion, and technological advancement in sensor miniaturization will further accelerate adoption across clinical and commercial settings.
- Healthcare systems are increasingly recognizing wearables as cost-effective tools for managing patient populations and generating real-world evidence to support clinical decision-making..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- The US wearables in pharma & biotech market will grow from $1,602.2M (2026) to $3,973.4M (2031) at a 19.9% CAGR.
- The US market is driven by remote patient monitoring adoption, clinical trial optimization, and real-world evidence generation.
- The US regulatory framework and FDA guidance on digital health accelerate commercialization and market penetration.
- The US pharmaceutical and biotech sectors are increasingly integrating wearables for patient engagement and outcome tracking.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
US Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
US: WEARABLES IN PHARMA & BIOTECH MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CONTRACT RESEARCH ORGANIZATIONS | 381 | 453.1 | 542 | 651.2 | 785.6 | 950.9 | 1154.7 | 1405.8 | 21 |
| HEALTHCARE PROVIDERS & CLINICIANS | 120.8 | 141.2 | 165.8 | 195.7 | 231.9 | 275.6 | 328.8 | 393.1 | 18.8 |
| OTHER END USERS | 71.6 | 83 | 96.6 | 112.9 | 132.4 | 155.5 | 183.1 | 215.9 | 17.4 |
| PHARMACEUTICAL & BIOTECH COMPANIES | 573.1 | 674.1 | 797.7 | 947.9 | 1131 | 1354.1 | 1626.5 | 1958.5 | 19.7 |
| TOTAL | 1146.5 | 1351.3 | 1602.2 | 1907.7 | 2280.9 | 2736.1 | 3293.1 | 3973.4 | 19.9 |
Target Audience
- Pharmaceutical Companies : US pharma executives need this data to evaluate wearable integration opportunities in drug development, clinical trials, and post-market surveillance to improve efficacy monitoring and gain competitive advantages in precision medicine.
- Biotech Firms : Biotech innovators require US market insights to identify emerging wearable technology applications, assess market entry feasibility, and align product development strategies with regulatory pathways and healthcare provider adoption trends.
- Medical Device Manufacturers : Device companies need comprehensive US market analysis to understand wearable integration opportunities, competitive positioning, and reimbursement landscapes to optimize product portfolios and distribution strategies.
- Healthcare Investors & Venture Capitalists : Investment professionals require validated US market data and growth projections to identify promising wearable healthcare startups, assess portfolio company valuations, and make informed funding decisions in the digital health space.
- Healthcare Providers & Health Systems : US hospital networks and healthcare systems need market intelligence to evaluate wearable technology vendors, understand implementation ROI, and develop remote monitoring programs that enhance patient outcomes and operational efficiency.
Key Companies in the US Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise US market valuation data ($1,602.2M in 2026) and verified 19.9% CAGR projections through 2031 to support investment decisions and strategic planning in the American wearables healthcare sector.
- Competitive Landscape Intelligence : Gain detailed insights into US-specific competitive dynamics, key market players, and differentiation strategies to identify partnership opportunities and market positioning advantages in the rapidly expanding wearables segment.
- Regulatory & Reimbursement Pathways : Access comprehensive analysis of FDA approval trends, reimbursement policies, and regulatory requirements specific to the US market to accelerate product commercialization and market entry strategies.
- Clinical Application Opportunities : Identify high-value use cases in US clinical trials, remote monitoring programs, and real-world evidence generation to prioritize R&D investments and develop targeted solutions for pharmaceutical and biotech applications.
- Strategic Growth Planning : Leverage US-specific market forecasts and trend analysis to develop data-driven go-to-market strategies, resource allocation plans, and long-term business expansion roadmaps in the American healthcare wearables ecosystem.
Frequently asked questions
What is the current size of the US wearables in pharma & biotech market?
The US market is valued at $1,602.2 million in 2026 and is expected to grow to $3,973.4 million by 2031.
What is the projected growth rate for the US wearables market?
The US wearables in pharma & biotech market is projected to grow at a compound annual growth rate (CAGR) of 19.9% from 2026 to 2031.
What are the primary drivers of growth in the US market?
Key drivers include remote patient monitoring adoption, integration of digital therapeutics, FDA regulatory support for digital health, and increased use in clinical trials and real-world evidence collection.
How are US pharmaceutical companies using wearables?
US pharma companies are leveraging wearables for patient monitoring, clinical trial optimization, real-world evidence generation, and improving patient engagement and adherence.
What role does FDA regulation play in the US market?
FDA guidance on digital health and software as a medical device (SaMD) provides a clear regulatory pathway, accelerating commercialization and market adoption of wearable solutions in the US.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- South Korea Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report